CAMP4 THERAPEUTICS CORPORATION

Healthcare · Biotechnology

4.20$ -1.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

CAMP4 THERAPEUTICS CORPORATION (CAMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 118 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CAMP
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	30	28	26	56	50	57	90	98	197	204	230	143	70	57	55	51	151	179	203	384	408	473	604	496	442	402	103	55	78	118
Current Assets	20	20	20	41	36	46	53	67	89	99	114	67	44	37	38	40	107	92	127	299	207	276	403	238	215	194	84	40	66	114
Cash	3.2	4.4	9.3	3.1	10	23	22	23	31	46	38	6.6	6.9	3.0	4.2	5.6	63	19	34	139	94	133	257	107	92	91	83	38	64	110
Cash & Short-Term Investments	3.2	4.4	9.3	3.1	10	23	22	23	31	46	38	6.6	6.9	3.0	4.2	5.6	63	28	44	228	100	156	274	107	92	91	83	38	64	110
Receivables	7.3	6.1	5.0	16	12	8.2	16	19	27	29	38	20	14	17	17	14	19	37	48	49	67	72	78	72	68	59	0.7	0.4	0.1	0.2
Inventory	8.2	6.9	4.0	13	10	9.5	13	20	21	18	26	25	15	11	9.9	10	14	15	19	17	29	36	32	37	32	20	24	–	–	–
Goodwill	–	–	–	3.8	3.6	–	–	–	–	–	90	29	–	–	–	–	1.1	15	15	17	73	73	81	106	94	94	94	–	–	–
Intangible Assets	–	–	–	3.8	3.6	3.3	21	21	97	97	19	24	6.5	5.1	4.0	2.7	4.6	29	23	17	67	52	47	46	39	33	27	–	–	–
Total Liabilities	5.4	6.1	5.3	27	20	19	31	32	38	28	78	70	46	38	38	27	33	46	51	195	244	274	398	358	343	322	180	179	15	70
Current Liabilities	4.9	5.0	4.9	27	15	15	18	25	30	22	39	40	45	33	33	24	29	42	47	50	77	96	84	121	107	95	7.9	7.8	9.6	16
Short-Term Debt	0.9	0.7	0.6	5.0	0.6	0.9	3.0	3.6	2.9	2.2	2.9	5.3	21	5.9	7.5	1.1	2.3	1.2	0.6	6.8	11	32	37	38	11	7.7	2.4	3.1	3.1	0.3
Accounts Payable	2.1	1.9	2.6	9.2	5.7	5.7	12	17	18	12	26	11	5.4	16	14	9.5	12	21	24	25	30	35	40	28	37	31	2.2	1.0	1.2	0.2
Shareholders' Equity	24	21	20	28	30	38	59	65	158	176	151	73	23	19	18	25	118	133	151	189	164	199	206	138	99	80	-78	-124	63	48
Retained Earnings	10	7.5	6.1	4.7	6.2	11	16	22	30	44	13	-71	-121	-132	-135	-130	-85	-73	-57	-40	-47	-19	-2.2	-82	-129	-157	-111	-160	-212	-292
Shares Outstanding	12	12	12	12	14	14	15	15	22	23	23	24	25	25	27	28	30	36	37	37	36	36	35	34	1.5	1.5	36	12	20	30

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings